PROGRAM AT-A-GLANCE

Full Program

8:00 AM - 5:00 PM - Asynchronous Virtual Presentations ()

8:30 - 9:45 AM - Concurrent Oral Sessions (Student Union Building & Magruder Hall)

• 103- SUB Georgian A 8:30:  (SUB Georgian A)
• 104- SUB Georgian B 8:30:  (SUB Georgian B)
• 105- SUB Georgian C 8:30:  (SUB Georgian C)
• 106- MG 2001 8:30:  (MG 2001)
• 107- MG 1000 8:30:  (MG 1000)
• 108- MG 1098 8:30:  (MG 1098)
• 109- MG 2007 8:30:  (MG 2007)
• 101-3201 SUB 3201 8:30:  (SUB 3201 )
• 102-3202 SUB 3202 8:30:  (SUB 3202 )
• 100-3203 SUB 3203 8:30:  (SUB 3203)

10:00 - 11:15 AM - Concurrent Oral Sessions (Student Union Building & Magruder Hall)

• 200- SUB 3203 10:00:  (SUB 3203)
• 201- SUB 3201 10:00:  (SUB 3201)
• 202- SUB 3202 10:00:  (SUB 3202)
• 203- SUB Georgian A 10:00:  (SUB Georgian A)
• 204- SUB Georgian B 10:00:  (SUB Georgian B)
• 205- SUB Georgian C 10:00:  (SUB Georgian C)
• 206- MG 2001 10:00:  (MG 2001)
• 207- MG 1000 10:00:  (MG 1000)
• 208- MG 1098 10:00:  (MG 1098)
• 209- MG 2007 10:00:  (MG 2007)

11:45 AM - 12:45 PM - Plenary Address - W. David Arnold, MD (Magruder Hall 2001)

W. David Arnold, MD is a physician-scientist and tenured Professor of Physical Medicine & Rehabilitation, Neurology, and Medical Pharmacology & Physiology at the University of Missouri, where he serves as Executive Director of the Roy Blunt NextGen Precision Health Initiative and is a founding leader of the Center for Translational Neurogenetics. With a nontraditional training trajectory that bridges clinical medicine, translational neuroscience, and therapeutic development, his research focuses on translational neuromuscular physiology in the context of health, aging, and disease. His work has helped to define neural contributions to sarcopenia and mechanisms of neuromuscular decline across the lifespan, and his team has published the first efforts to develop neurotherapeutics for the treatment of age-related loss of physical function. Dr. Arnold has contributed to the development of gene-replacement therapy for spinal muscular atrophy (SMA), therapeutic development efforts in Charcot?Marie?Tooth disease (CMT), and advances in genetic and molecular therapies for neuromuscular disorders such as myotonic dystrophy type 1 (DM1). He is the executive director of the NextGen Precision Health Initiative, the largest investment in translational research in the history of the University of Missouri System. He co-directs the MD/PhD program at Missouri, holds national leadership roles in physician-scientist training including the Rehabilitation Medicine Scientist Training Program (RMSTP), chair of the research committee of the AAP, and leads multidisciplinary teams advancing precision therapies for neuromuscular and neurogenetic disease.

1:00 pm - 2:30 pm - Music & Theatre Performance Presentations (SUB Alumni)

• 309- Alumni 1:15: Performance (SUB Alumni room)

1:00 - 2:15 PM - Concurrent Oral Sessions (Student Union Building & Magruder Hall)

• 300- SUB 3203 1:00:  (SUB 3203)
• 302- SUB 3202 1:00:  (SUB 3202)
• 303- SUB Georgian A 1:00:  (SUB Georgian A)
• 304- SUB Georgian B 1:00:  (SUB Georgian B)
• 305- SUB Georgian C 1:00:  (SUB Georgian C)
• 306- MG 2001 1:00:  (MG 2001)
• 307- MG 1000 1:00:  (MG 1000)
• 308- MG 1098 1:00:  (MG 1098)
• 301- SUB 3201 1:00:  (SUB 3201)

2:30 - 3:30 pm - Poster Session (Student Union Building Activities Room)

The Poster Session will be held in the Activities Room on the 3rd floor of the Student Union Building. All students and faculty are encouraged to visit throughout the afternoon.

• 400- Poster Session:  (Activities Room)

4:00 - 5:00 PM - Studio Art Reception (Ophelia Parrish Art Gallery)